OVERVIEW

The Scripps Arrhythmias and Cardiomyopathy in Women Symposium is designed to increase competence regarding the recognition and management of cardiovascular disease in women. The symposium will explore new and emerging risk factors for women’s heart disease while highlighting areas of discrepancy in care management related to gender. Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for women afflicted with heart failure, cardiac arrhythmias, and cardiomyopathies. The goal of the activity is to improve outcomes for women with cardiovascular disease and arrhythmias as well as provide educational interventions for both primary and secondary prevention.

LEARNING OBJECTIVES

After attending this live activity, participants should be able to:

• Discuss cardiovascular disease, conditions and risk factors which are more common and/or unique to women.
• Identify the varied and atypical presentation of heart disease and arrhythmia in women.
• Analyze the underutilization of guideline-recommended medical and device therapies in women compared to men.
• Assess the cardiovascular risk reduction benefits of newer antihyperglycemic therapies in women.
• Recognize the symptoms of transthyretin amyloidosis and recommended diagnostic tests.
• Summarize the effects on menopause on cardiovascular risk and the role of hormone replacement therapy.
• Describe management of common cardiovascular conditions in high-risk pregnancies.
• Examine the association of postural tachycardia syndrome with COVID-19, as well as cardiac symptoms and long-term sequelae.

ACCREDITATION

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

For more information please visit the official event page.